NVCT
Nuvectis Pharma Inc
21.40$
-2.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | 100.0% | – | – | – | |
| – | – | 12,908.7% | – | – | – | |
| – | – | -12,808.7% | – | – | – | |
| – | – | 8,877.2% | – | – | – | |
| – | – | 4,031.5% | – | – | – | |
| – | – | 12,908.7% | – | – | – | |
| – | – | -12,908.7% | – | – | – | |
| – | – | 100.0% | – | – | – | |
| – | – | -12,808.7% | – | – | – | |
| – | – | -200.0% | – | – | – | |
| – | – | -12,608.7% | – | – | – | |
| – | – | -12,708.7% | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.